Second International Medical Device Innovation Summit to Be Held in Gaochun, Nanjing

In recent years, as a strategic emerging industry receiving key national support, the medical device sector has experienced rapid growth, bolstered by a series of policies ranging from deepened review and approval reforms, innovation in high-value consumables, Diagnosis-Related Groups (DRG), and Supply, Processing, and Distribution (SPD) models, to medical consortia, tiered diagnosis and treatment, and the Marketing Authorization Holder (MAH) system for medical devices. Statistics show that China’s medical device market size reached RMB 628.5 billion in 2019, and is projected to exceed RMB 900 billion by 2022.

“To further analyze the innovation, transformation, and development of China’s medical device industry, gain insights into development trends, and promote the integration of industry and capital, this event is hosted by the People’s Government of Gaochun District, organized by the Science and Technology Bureau of Gaochun District and VCBeat, and co-organized by Jiangsu Gaochun High-Tech Industrial Development Zone.”The 2nd International Summit on Medical Device Innovation"will be held onJuly 28, 2020InNanjing · GaochunHeld.

This conference will be held with2020 Medical Device Innovation Vitality ListTaking the release as an opportunity to deeply focus onGenetic Testing, In Vitro Diagnostics...and other hot topics, gathering the most active medical device innovators, listed companies, financial institutions, and healthcare organizations from China and abroad to create a premier industry event for the medical device sector.

Future Trends: Four 2020 Medical Device Innovation Vitality Lists Released On-Site

Focusing on Four Hot Tracks in the Medical Device Sector: A Curated Selection of Chemiluminescence, Home Medical Devices, Orthopedic Implants, and Cutting-Edge Tech Products. Who Are the 2020 Innovative Vitality Enterprises in the Medical Device Industry?At the 2020 Second International Summit on Medical Device Innovation, the 2020 Medical Device Innovation Vitality Rankings will be released. Witness the unveiling of four lists: which 40 companies will emerge as the most innovative?

Supporting Investment Institutions

Heavyweight Guests: Over 18 Medical Device Industry Leaders to Engage in Dialogue with You

Yuan-Ting Zhang, Academician of the International Academy of Medical and Biological Engineering, and Jie Tian, Director of the Key Laboratory of Molecular Imaging of the Chinese Academy of Sciences, will join forces with executives from multinational giant Johnson & Johnson, NMPA medical device review experts, founders of high-quality innovative medical device enterprises, forward-looking medical device investors, and senior department directors to discuss the future of medical devices. More guests are being confirmed; stay tuned.

Partially Confirmed Guests:

Zhang Yuanting, Academician of the International Academy of Medical and Biological Engineering, IEEE Fellow, and Fellow of the American Institute for Medical and Biological Engineering

Tian Jie, Director of the Key Laboratory of Molecular Imaging, Chinese Academy of Sciences

Dong Yansheng, NMPA Medical Device Review Expert

Wang Jinhe, Vice President of External Affairs and Market Access, Johnson & Johnson Medical China

Sun Qi, Founding Managing Partner of Daotong Capital

Zhao Xiangwei, Vice Dean of the School of Biological Science and Medical Engineering, Southeast University

Yang Song, Chief Analyst of the Pharmaceutical Industry at Cinda Securities

Wang Yaqi，Co-founder and Chairman of Raybiotech

Du Zhengping, Co-founder of Aoran Biotech

Zhou Quan, Managing Director, Legend Capital

Li Gang, Founder of Changjiang Bio

More speakers to be confirmed...

In-Depth Content: Two Roundtable Discussions Focus on Industry Trends and the Development Direction of In Vitro Diagnostics

In recent years, domestic medical device innovation has surged. The primary market has seen the emergence of unicorn companies such as United Imaging Healthcare, Venus Medtech, and MicroPort CardioFlow. In the secondary market, Mindray’s market capitalization has exceeded RMB 300 billion, while Chunli Medical’s stock price has increased more than tenfold over two years. In terms of specific segments,In 2018, the market size of China's in vitro diagnostics (IVD) industry reached RMB 60.4 billion, representing a year-on-year growth of 18.4%. It is projected that the annual growth rate will remain at approximately 18% in the coming years, making China one of the fastest-growing IVD markets globally.

All these signs seem to herald the arrival of the golden age for domestically produced medical devices in China. What trends will shape the future development of China’s medical device industry? Which subsectors within the domestic medical device market hold greater promise? At this summit, the morning roundtable discussion will focus onDevelopment Opportunities for Medical Devices in the Post-Pandemic Era, the afternoon roundtable session will delve into specialized subfields, withSenior Investors in the IVD Industry, High-Quality Innovative EnterprisesPrecision Dialogue。